337 related articles for article (PubMed ID: 18688283)
21. KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo.
D'Alessandro G; Catalano M; Sciaccaluga M; Chece G; Cipriani R; Rosito M; Grimaldi A; Lauro C; Cantore G; Santoro A; Fioretti B; Franciolini F; Wulff H; Limatola C
Cell Death Dis; 2013 Aug; 4(8):e773. PubMed ID: 23949222
[TBL] [Abstract][Full Text] [Related]
22. Activation of the KCa3.1 channel contributes to traumatic scratch injury-induced reactive astrogliosis through the JNK/c-Jun signaling pathway.
Yi M; Dou F; Lu Q; Yu Z; Chen H
Neurosci Lett; 2016 Jun; 624():62-71. PubMed ID: 27163196
[TBL] [Abstract][Full Text] [Related]
23. Histone Deacetylases Enhance Ca
Matsui M; Terasawa K; Kajikuri J; Kito H; Endo K; Jaikhan P; Suzuki T; Ohya S
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262728
[TBL] [Abstract][Full Text] [Related]
24. High glucose induces CCL20 in proximal tubular cells via activation of the KCa3.1 channel.
Huang C; Pollock CA; Chen XM
PLoS One; 2014; 9(4):e95173. PubMed ID: 24733189
[TBL] [Abstract][Full Text] [Related]
25. Selective inhibition of KCa3.1 channels mediates adenosine regulation of the motility of human T cells.
Chimote AA; Hajdu P; Kucher V; Boiko N; Kuras Z; Szilagyi O; Yun YH; Conforti L
J Immunol; 2013 Dec; 191(12):6273-80. PubMed ID: 24227782
[TBL] [Abstract][Full Text] [Related]
26. Calcium-dependent potassium channels control proliferation of cardiac progenitor cells and bone marrow-derived mesenchymal stem cells.
Vigneault P; Naud P; Qi X; Xiao J; Villeneuve L; Davis DR; Nattel S
J Physiol; 2018 Jun; 596(12):2359-2379. PubMed ID: 29574723
[TBL] [Abstract][Full Text] [Related]
27. Crocin Improves the Endothelial Function Regulated by Kca3.1 Through ERK and Akt Signaling Pathways.
Yang H; Li X; Liu Y; Li X; Li X; Wu M; Lv X; Chunhua C; Ding X; Zhang Y
Cell Physiol Biochem; 2018; 46(2):765-780. PubMed ID: 29621746
[TBL] [Abstract][Full Text] [Related]
28. KCa3.1 inhibition switches the phenotype of glioma-infiltrating microglia/macrophages.
Grimaldi A; D'Alessandro G; Golia MT; Grössinger EM; Di Angelantonio S; Ragozzino D; Santoro A; Esposito V; Wulff H; Catalano M; Limatola C
Cell Death Dis; 2016 Apr; 7(4):e2174. PubMed ID: 27054329
[TBL] [Abstract][Full Text] [Related]
29. The potassium channel KCa3.1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke.
Chen YJ; Nguyen HM; Maezawa I; Grössinger EM; Garing AL; Köhler R; Jin LW; Wulff H
J Cereb Blood Flow Metab; 2016 Dec; 36(12):2146-2161. PubMed ID: 26661208
[TBL] [Abstract][Full Text] [Related]
30. The KCa3.1 blocker TRAM-34 inhibits proliferation of fibroblasts in paraquat-induced pulmonary fibrosis.
Xie H; Lu J; Zhu Y; Meng X; Wang R
Toxicol Lett; 2018 Oct; 295():408-415. PubMed ID: 30036685
[TBL] [Abstract][Full Text] [Related]
31. miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma.
Chen Y; Kuang D; Zhao X; Chen D; Wang X; Yang Q; Wan J; Zhu Y; Wang Y; Zhang S; Wang Y; Tang Q; Masuzawa M; Wang G; Duan Y
Oncotarget; 2016 Sep; 7(36):58148-58161. PubMed ID: 27531900
[TBL] [Abstract][Full Text] [Related]
32. The role and mechanism of K
Ma XZ; Pang ZD; Wang JH; Song Z; Zhao LM; Du XJ; Deng XL
Exp Cell Res; 2018 Aug; 369(2):208-217. PubMed ID: 29792849
[TBL] [Abstract][Full Text] [Related]
33. Increased Interleukin-10 Expression by the Inhibition of Ca
Ohya S; Matsui M; Kajikuri J; Endo K; Kito H
J Pharmacol Exp Ther; 2021 Apr; 377(1):75-85. PubMed ID: 33504590
[TBL] [Abstract][Full Text] [Related]
34. The Ca²⁺-activated K⁺ channel KCa3.1 as a potential new target for the prevention of allograft vasculopathy.
Chen YJ; Lam J; Gregory CR; Schrepfer S; Wulff H
PLoS One; 2013; 8(11):e81006. PubMed ID: 24312257
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of KCa3.1 K(+) channel in mesenteric lymph node CD4(+) T lymphocytes from a mouse model of dextran sodium sulfate-induced inflammatory bowel disease.
Ohya S; Fukuyo Y; Kito H; Shibaoka R; Matsui M; Niguma H; Maeda Y; Yamamura H; Fujii M; Kimura K; Imaizumi Y
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(10):G873-85. PubMed ID: 24674776
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of KCa3.1 promotes human airway smooth muscle cell phenotypic modulation.
Yu ZH; Wang YX; Song Y; Lu HZ; Hou LN; Cui YY; Chen HZ
Pharmacol Res; 2013 Nov; 77():30-8. PubMed ID: 24055799
[TBL] [Abstract][Full Text] [Related]
37. The Ca(2+)-activated K(+) channel KCa3.1 compartmentalizes in the immunological synapse of human T lymphocytes.
Nicolaou SA; Neumeier L; Peng Y; Devor DC; Conforti L
Am J Physiol Cell Physiol; 2007 Apr; 292(4):C1431-9. PubMed ID: 17151145
[TBL] [Abstract][Full Text] [Related]
38. Targeting the KCa3.1 channel suppresses diabetes-associated atherosclerosis via the STAT3/CD36 axis.
Jiang XX; Bian W; Zhu YR; Wang Z; Ye P; Gu Y; Zhang H; Zuo G; Li X; Zhu L; Liu Z; Sun C; Chen SL; Zhang DM
Diabetes Res Clin Pract; 2022 Mar; 185():109776. PubMed ID: 35149165
[TBL] [Abstract][Full Text] [Related]
39. Functional role of the KCa3.1 potassium channel in synovial fibroblasts from rheumatoid arthritis patients.
Friebel K; Schönherr R; Kinne RW; Kunisch E
J Cell Physiol; 2015 Jul; 230(7):1677-88. PubMed ID: 25545021
[TBL] [Abstract][Full Text] [Related]
40. K
Lu R; Flauaus C; Kennel L; Petersen J; Drees O; Kallenborn-Gerhardt W; Ruth P; Lukowski R; Schmidtko A
Neuropharmacology; 2017 Oct; 125():386-395. PubMed ID: 28823609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]